majority of breast CA found where
upper outer quadrant (closest to armpit)
Tail of Spence
extension of breast tissue that extends into axilla
etiology/risk factors
mutation of BRCA1 and 2 gene results in what
growth suppression limited & malignant cells proliferate rapidly
why does inc age inc risk of breast CA
d/t inc exposure of carcinogens
what hormonal factors inc risk of breast CA
HRT
hormone replacement therapy of estrogen & progestin (a form of progesterone)
why does entering menopause late inc risk of breast CA
Breasts exposed to estrogen for longer period of time –> inc risk (estrogen = breast CA risk factor)
why does early menarche inc risk of breast CA
Extended estrogen exposure = inc risk
why does nulliparity inc risk of breast CA
d/t no break in menstrual cycle
ductal carcinoma in situ characteristics
- stage 0 = tumor is in early stages (“pre-cancerous”)
infiltrating ductal carcinoma
ductal origin
tumor arises from duct system and invades surrounding tissues
proximal mets of infiltrating ductal carcinoma to where
axillary lymph nodes
distal mets of infiltrating ductal carcinoma to where
liver, bone, brain
mnfts
- retracted nipples, discharge, & edema
Dx
what does biopsy measure
- SLN assessment (sentinel lymph nodes)
tumor marker CEA
carcinoembryonic antigen test that measures amount of protein in blood to determine how widespread CA is (more CA cells = inc CEA)
Tx
hormone therapy drugs
- Es inhibitors
Tamoxifen
Synthetic non-steroidal anti-estrogen
Es inhibitors Fx
Block synthesis of estrogen
what Sx for breast CA